Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | REN | P00797 | 20/20 | 0.69 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12119642 | 1.00 | REN (0.69) | REN | |
| SCHEMBL428235 | 0.88 | REN (0.74) | REN | |
| SCHEMBL14129365 | 0.85 | REN (0.68) | REN | |
| SCHEMBL14097890 | 0.85 | REN (0.68) | REN | |
| SCHEMBL14139842 | 0.85 | REN (0.68) | REN | |
| SCHEMBL1596832 | 0.85 | REN (0.77) | REN | |
| SCHEMBL1596680 | 0.85 | REN (0.77) | REN | |
| SCHEMBL12122446 | 0.85 | REN (0.70) | REN | |
| SCHEMBL424488 | 0.85 | REN (0.73) | REN | |
| SCHEMBL8259903 | 0.85 | REN (0.85) | REN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1937248-B1 | ALCANOIC ACID AMIDES SUBSTITUTED BY SATURATED O-HETEROCYCLES | NOVARTIS AG (CH) | 2010-06-02 | — | — | EP | claimed |
| US-8058307-B2 | Alcanoic acid amides substituted by saturated O-heterocycles | NOVARTIS AG (CH) | 2011-11-15 | — | — | US | disclosed |
| US-20110144197-A1 | ALCANOIC ACID AMIDES SUBSTITUTED BY SATURATED O-HETEROCYCLES | SPEEDEL EXPERIMENTA AG (CH) | 2011-06-16 | — | — | US | disclosed |
| EP-1937248-B1 | ALCANOIC ACID AMIDES SUBSTITUTED BY SATURATED O-HETEROCYCLES | NOVARTIS AG (CH) | 2010-06-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110144197-A1 | ALCANOIC ACID AMIDES SUBSTITUTED BY SATURATED O-HETEROCYCLES | REN, AGTR1, ACE | REN 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.